The increased prevalence of MetS among women could be attributable to hormonal oral contraceptive uses that can decrease the sensitivity of muscles to insulin which in turn can lead to impaired glucose metabolism and dyslipidemia [64]. This evidence concerns the gene INS and metabolic syndrome.